 |
|
Identification of genetic risk factor for coeliac disease promises improved treatment
June 11, 2007An international research consortium investigating the genetic causes of intestinal inflammatory conditions has identified a new genetic risk factor for coeliac disease. The findings, published online today (10 June 2007) in the science journal Nature Genetics, could pave the way towards improved diagnostics and treatments for the common, lifelong complaint.
Led by David van Heel, Professor of Gastrointestinal Genetics at Queen Mary, University of London, the study - funded by the charity Coeliac UK, and the Wellcome Trust - has revealed that those suffering from coeliac disease lack a protective DNA sequence in a specific gene region, otherwise found in healthy individuals.
Behind the success of the study are the Human Genome Project and the Hap Map Project, international research efforts to reveal the entire sequence of all the human chromosomes - and the functional units embedded within - and to correlate that information to common sequence variation in the human population.
Dr Panos Deloukas, Senior Investigator in Human Genetics at the Wellcome Trust Sanger Institute, and part of the research consortium, said: "These resources coupled with technological advances have enabled us to scan variation across the human genome in large numbers of people for association to disease." The Sanger Institute made available to the study the genome data on 1500 British individuals used as controls (i.e without coeliac disease). The consortium studied over four thousand individuals with and without coeliac disease, amongst British, Irish and Dutch populations.
What they found is that healthy individuals more often have a protective DNA sequence in the interleukin-2 and interleukin-21 gene region than individuals with coeliac disease. Interleukin-2 and interleukin-21 are cytokine proteins secreted by white blood cells that control inflammation. It is likely that the protective DNA sequence leads to different amounts of these cytokines being produced - than in someone with coeliac disease - providing defence against intestinal inflammation.
Coeliac disease is found in around 1 in 100 of the British population. It is caused by intolerance to gluten - a protein found in wheat, barley and rye - which results in damage to the gut, preventing normal digestion and absorption of food. If undetected it can lead to, amongst other things, anaemia, poor bone health, and weight loss. Although the majority of people are diagnosed in mid-life, symptoms can present themselves at anytime, for example during illness, stress, or post-trauma. There is a strong inherited (genetic) risk.
Professor David van Heel, chief investigator in the study, said; "We previously knew that coeliac individuals had a specific tissue type which recognised wheat proteins. We did not know why healthy individuals who had the same tissue type did not develop symptoms or disease. The first findings from our study suggest that interleukin genes that control inflammation are critical. We expect to find more disease risk factors from further in-depth analysis of the genome wide data."
Sarah Sleet, Chief Executive of Coeliac UK said: 'This research heralds an important breakthrough in understanding better who is likely to develop coeliac disease. Around 1 in 100 people develop the disease but predicting who is susceptible is like searching for a needle in a haystack. Currently genetic testing is a blunt instrument which can only narrow down the search to around one third of the general population'.
Queen Mary, University of London
Dr Panos Deloukas, Senior Investigator in Human Genetics at the Wellcome Trust Sanger Institute, and part of the research consortium, said: "These resources coupled with technological advances have enabled us to scan variation across the human genome in large numbers of people for association to disease." The Sanger Institute made available to the study the genome data on 1500 British individuals used as controls (i.e without coeliac disease). The consortium studied over four thousand individuals with and without coeliac disease, amongst British, Irish and Dutch populations.
What they found is that healthy individuals more often have a protective DNA sequence in the interleukin-2 and interleukin-21 gene region than individuals with coeliac disease. Interleukin-2 and interleukin-21 are cytokine proteins secreted by white blood cells that control inflammation. It is likely that the protective DNA sequence leads to different amounts of these cytokines being produced - than in someone with coeliac disease - providing defence against intestinal inflammation.
Coeliac disease is found in around 1 in 100 of the British population. It is caused by intolerance to gluten - a protein found in wheat, barley and rye - which results in damage to the gut, preventing normal digestion and absorption of food. If undetected it can lead to, amongst other things, anaemia, poor bone health, and weight loss. Although the majority of people are diagnosed in mid-life, symptoms can present themselves at anytime, for example during illness, stress, or post-trauma. There is a strong inherited (genetic) risk.
Professor David van Heel, chief investigator in the study, said; "We previously knew that coeliac individuals had a specific tissue type which recognised wheat proteins. We did not know why healthy individuals who had the same tissue type did not develop symptoms or disease. The first findings from our study suggest that interleukin genes that control inflammation are critical. We expect to find more disease risk factors from further in-depth analysis of the genome wide data."
Sarah Sleet, Chief Executive of Coeliac UK said: 'This research heralds an important breakthrough in understanding better who is likely to develop coeliac disease. Around 1 in 100 people develop the disease but predicting who is susceptible is like searching for a needle in a haystack. Currently genetic testing is a blunt instrument which can only narrow down the search to around one third of the general population'.
Queen Mary, University of London
Coeliac Disease Current Events and Coeliac Disease News RSSBlood counts are clues to human disease
A new genome-wide association study published today in Nature Genetics begins to uncover the basis of genetic variations in eight blood measurements and the impact those variants can have on common human diseases.
New link found between osteoporosis and coeliac disease
People with coeliac disease may develop osteoporosis because their immune system attacks their bone tissue, a new study has shown.
Are vitamin supplements effective in celiac disease patients?
Coeliac disease is a typical example of a malabsorption syndrome conferring increased risk for various deficiency states, including folate and vitamin B12. Hyperhomocysteinemia is significantly more frequent in patients with newly diagnosed coeliac disease than healthy controls.
Discovery of new family of genetic mutations involved in inflammatory intestinal disease
The discovery of new genetic mutations involved in inflammatory intestinal disorders could lead to a better understanding of these common conditions.
Scientists uncover further steps leading to celiac disease
Scientists who last year identified a new genetic risk factor for coeliac disease, have, following continued research, discovered an additional seven gene regions implicated in causing the condition.
Researchers study the possible relationship between myopathies and coeliac disease
Inflammatory myopathies are immunological diseases that lead to inflammations in muscular tissue. As of yet, little is known about the cause of these myopathies, but it is believed to be an abnormal immune response by our bodies.
Inflammatory bowel disease is a risk factor for thrombosis
People with inflammatory bowel disease (IBD) are more than three times as likely to develop blood clots in their veins (venous thromboembolism), finds new research in Gut. Thromboembolism is a serious and potentially life threatening event. For many years, patients with IBD were thought to be at increased risk, but the evidence has been inconsistent. Furthermore, it is not known if this risk is specific for IBD or if it is shared by other chronic inflammatory diseases or bowel disorders, such as rheumatoid arthritis or coeliac disease. Researchers surveyed 618 patients with IBD, 243 with rheumatoid arthritis, 207 with coeliac disease. All three patient groups were compared with matched contr
Coeliac disease may predict schizophrenia
A history of coeliac disease (gluten intolerance) is a risk factor for developing schizophrenia, finds a study in this week's BMJ. Previous studies have suggested an association between these two disorders. Researchers identified 7,997 people older than 15 who were admitted to any Danish psychiatric unit for the first time between 1981 and 1998 with a diagnosis of schizophrenia. For each case, they randomly selected 25 controls, matched by year of birth and sex, and identified any history of coeliac disease, ulcerative colitis, or Crohn's disease in cases, controls, and their parents. They found a moderately strong risk relation between coeliac disease and schizophrenia. However, the authors
Coeliac disease - the tip of the iceberg
The full extent of a hidden condition which goes largely undetected among British children - and unnoticed until adulthood - has been identified by doctors in Bristol. Their research suggests that until now the scale of coeliac disease among UK children has been under-estimated. Currently, fewer than one in 2,500 children is treated for the disease, but the study of children in Bristol has shown that it probably affects one child in 100, although most have no overt symptoms. Significantly, the figures appear to indicate that coeliac disease, an intolerance to gluten, is triggered in childhood, although the symptoms might not appear until years later. The extent of the condition is revealed
Summer babies at greater risk of developing coeliac disease
The risk of developing coeliac disease is higher for children born in the summer compared with the winter, finds a study in the Journal of Epidemiology & Community Health.
More Coeliac Disease Current Events and Coeliac Disease News Articles
 |
A Primitive Diet: A Book of Recipes free from Wheat/Gluten, Dairy Products, Yeast and Sugar: For people with Candidiasis, Coeliac Disease, Irritable Bowel ... and those just wanting to become healthy by Beverley Southam (Author) A Primitive Diet is a book of information and recipes free from gluten, yeast, sugar, dairy products, large amounts of meat and grain, and processed foods that today are a major proportion of the modern "western" diet. These recipes are suitable for people of all ages. Don't be put off trying them just because you consider yourself healthy ... you'll be surprised at the gourmet delights within.What did Primitive Man eat? He gathered fruits, berries, nuts, greens and roots from the soil. Herbs were his medicine. If he was quick and cunning he caught a small animal, fish or bird, or would have found a bird's egg.The exciting recipes contained between these covers have been created by Beverley Southam from Primitive Man's vast outdoor pantry, to solve serious health problems of her family... |
 |
The Ultimate Gluten-Free Diet: The Complete Guide to Coeliac Disease and Gluten-Free Cookery by Dr. Peter Rawcliffe (Author), Ruth James (Author) Anyone, from babies to adults can develop Coeliac disease—a sensitivity to the protein called gluten, which is found in wheat and certain other cereals. The gluten causes damage to the absorbing areas of the gut, interfering with the absorption of nutrients and causing vitamin and mineral deficiency. In this fully revised and updated guide, authors offer reassuring and practical advice to sufferers of Coeliac disease, discussing symptoms and diagnosis, and introducing the gluten-free diet. This includes sound nutritional advice, hints and tips on adapting to a gluten-free lifestyle, and a wealth of delicious recipes for every occasion. Understanding the condition is halfway to coping with it. This excellent book helps you to do both. |
 |
Your Guide to Coeliac Disease (The Royal Society of Medicine) by Peter Howdle (Author) The Royal Society of Medicine Your Guide to Coeliac Disease is the patient's ultimate tool to understanding their illness, discovering invaluable advice, and empowering them to make informed choices and to regain control of their life. Written by the top UK expert in this field, in conjunction with an expert dietician, this is an easy-to-read guide to coeliac disease, the symptoms, the treatment available, and ultimately how to overcome this misunderstood yet common illness. The book opens by explaining how to recognise the disease, where it comes from, and who else in your family might get it. It then goes on to detail diagnosis, management and most importantly taking control. A section on who you might meet in the NHS and their role in the treatment of your illness gives you a greater... |
|
Management of Celiac (Coeliac) Disease by Sidney V. and Merrill P. (MD's) Haas (Author) | |
 |
Gluten sensitivity: Gluten sensitivity. Gluten immunochemistry, Coeliac disease, Gluten- sensitive enteropathy associated conditions, Gluten- sensitive ... Wheat allergy, Gluten- free diet by Frederic P. Miller (Editor), Agnes F. Vandome (Editor), John McBrewster (Editor) Gluten sensitivity. Gluten immunochemistry, Coeliac disease, Gluten- sensitive enteropathy associated conditions, Gluten- sensitive idiopathic neuropathies, Wheat allergy, Gluten- free diet |
![Monoclonal antibody-based competitive assay for the sensitive detection of coeliac disease toxic prolamins [An article from: Analytica Chimica Acta]](http://ecx.images-amazon.com/images/I/415FBN4EPVL._SL160_.jpg) |
Monoclonal antibody-based competitive assay for the sensitive detection of coeliac disease toxic prolamins [An article from: Analytica Chimica Acta] by M.C. Bermudo Redondo (Author), P.B. Griffin (Author), Garzon Ransanz (Author) This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: Current immunosorbent assays for gluten detection suffer from a number of drawbacks including lack of specificity (e.g. cross-reaction with coeliac disease non-toxic prolamins, detection of total gluten and not specifically coeliac disease toxic gluten) and an inability to detect quantitatively hydrolysates and prolamins present in rye, barley and, possibly, oats. Additionally, the extraction methods employed involve the use of strong reducing agents that are not compatible with enzyme-linked immunosorbent assay.... |
|
Coeliac disease: Proceedings of an international conference held at the Royal Postgraduate Medical School, London, 1969; by (15 Teviot Place, Edinburgh 1), Churchill Livingstone (Publisher) | |
|
The Global Village of Coeliac Disease (Perspectives on Coeliac Disease, Volume II) by Carlo Catassi (Author), Carlo Catassi (Editor), Alessio Fasano (Editor), Gino Roberto Corazza (Editor) Series of essays on coeliac disease in the various continents. Information about the clinical approach and quality of life of the people who suffer from this intolerance. 151 pages. | |
|
Helping nurses understand coeliac disease: coeliac disease affects a significant number of New Zealanders. It is important nurses understand the disease ... article from: Kai Tiaki: Nursing New Zealand by Catherine Wightman (Author) This digital document is an article from Kai Tiaki: Nursing New Zealand, published by Thomson Gale on August 1, 2007. The length of the article is 1765 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Helping nurses understand coeliac disease: coeliac disease affects a significant number of New Zealanders. It is important nurses understand the disease and the importance of a gluten-free diet.(EDUCATION) Author: Catherine Wightman Publication: Kai Tiaki: Nursing New Zealand (Magazine/Journal) Date: August 1, 2007 Publisher: Thomson Gale Volume: 13 Issue: 7 Page:... | |
|
Coeliac Disease: Clinical and Immunological Aspects (Comprehensive Summaries of Uppsala Dissertations, 839) by Tony Hansson (Author) |
| © 2009 BrightSurf.com |